miR-149-5p mitigates tumor necrosis factor-α-induced chondrocyte apoptosis by inhibiting TRADD

Shi-Cheng Xie1, Lin Yang2, Taipengfei Shu3

  • 1Department of Joint Surgery, the Affiliated Hospital of Jining Medical University, Jining, China.

Abstract

Insights

MicroRNA-149-5p protects against osteoarthritis by inhibiting TRADD-modulated caspase signaling, reducing chondrocyte apoptosis and inflammation. This pathway offers a potential therapeutic target for treating osteoarthritis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Osteoarthritis (OA) is characterized by chondrocyte apoptosis and cartilage degeneration.
  • Tumor necrosis factor-alpha (TNF-α) plays a significant role in inducing chondrocyte apoptosis in OA.

Purpose of the Study:

  • To investigate the role of microRNA-149-5p (miR-149-5p) in TNF-α-induced chondrocyte apoptosis.
  • To elucidate the underlying molecular mechanisms involving TRADD and caspase signaling.

Main Methods:

  • Establishment of an in vitro chondrocyte apoptosis model using TNF-α.
  • Transfection with miR-149-5p mimics or TRADD expression vectors.
  • Assessment of cell viability, apoptosis, inflammatory cytokines, and protein/mRNA expression via CCK8, Annexin V-FITC, ELISA, RT-qPCR, and Western blotting.

Main Results:

  • TNF-α induced chondrocyte apoptosis, inflammation, and activated TRADD and caspase-3/8 signaling.
  • TRADD was identified as a direct target of miR-149-5p, with miR-149-5p overexpression down-regulating TRADD.
  • miR-149-5p mimics attenuated TNF-α-induced apoptosis and inflammation, while TRADD overexpression counteracted these protective effects.

Conclusions:

  • miR-149-5p inhibits TNF-α-mediated chondrocyte damage by down-regulating TRADD and modulating caspase signaling.
  • The miR-149-5p/TRADD pathway presents a potential therapeutic target for osteoarthritis treatment.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K